T1	CHEM 12 25	ácido lipoico
#1	AnnotatorNotes T1	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T2	ANAT 44 50	sangre
#2	AnnotatorNotes T2	C0005767; Blood; Body Substance
T3	CHEM 71 77	hierro
#3	AnnotatorNotes T3	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T4	DISO 91 102	hipertensos
#4	AnnotatorNotes T4	C0020538; Hypertensive disease; Disease or Syndrome
T5	Observation 1419 1452	aumento del número de neutrófilos
#5	AnnotatorNotes T5	C1719335; Elevated leukocytes, unspecified; Finding
T6	CHEM 121 136	Ácido α-Lipóico
#6	AnnotatorNotes T6	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T7	CHEM 138 141	ALA
#7	AnnotatorNotes T7	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T8	PROC 166 185	recurso terapéutico
T9	DISO 253 256	HAS
#8	AnnotatorNotes T9	C0020538; Hypertensive disease; Disease or Syndrome
T10	DISO 199 213	daño oxidativo
#9	AnnotatorNotes T10	C5392203; Oxidative Damage; Cell or Molecular Dysfunction
T11	DISO 220 251	Hipertensión Arterial Sistémica
#10	AnnotatorNotes T11	C0020538; Hypertensive disease; Disease or Syndrome
T12	PROC 279 295	estudios in vivo
#11	AnnotatorNotes T12	C0681829; in vivo study; Research Activity
T13	CHEM 360 366	hierro
#12	AnnotatorNotes T13	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T14	CHEM 414 432	ácido Alfa-Lipóico
#13	AnnotatorNotes T14	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T15	PROC 442 451	hemograma
#14	AnnotatorNotes T15	C0009555; Complete Blood Count; Laboratory Procedure
T16	CHEM 470 476	hierro
#15	AnnotatorNotes T16	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T17	DISO 491 502	hipertensos
#16	AnnotatorNotes T17	C0020538; Hypertensive disease; Disease or Syndrome
T18	DISO 513 519	anemia
#17	AnnotatorNotes T18	C0002871; Anemia; Disease or Syndrome
T19	PROC 531 596	Estudio clínico doble-ciego, randomizado y controlado con placebo
#18	AnnotatorNotes T19	C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product + C0206034; Clinical Trials, Randomized; Research Activity
T20	PROC 656 683	distribuidos aleatoriamente
#19	AnnotatorNotes T20	C0034656; Randomization; Research Activity
T21	DISO 643 654	hipertensos
#20	AnnotatorNotes T21	C0020538; Hypertensive disease; Disease or Syndrome
T22	PROC 693 704	tratamiento
#21	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	CHEM 742 745	ALA
#22	AnnotatorNotes T23	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T24	PROC 804 811	placebo
#23	AnnotatorNotes T24	C0032042; Placebos; Therapeutic or Preventive Procedure
T25	PROC 874 886	intervención
#24	AnnotatorNotes T25	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T26	PROC 907 916	hemograma
#25	AnnotatorNotes T26	C0009555; Complete Blood Count; Laboratory Procedure
T27	CHEM 918 924	Hierro
#26	AnnotatorNotes T27	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T28	ANAT 925 931	Sérico
#27	AnnotatorNotes T28	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T29	CHEM 976 982	hierro
#28	AnnotatorNotes T29	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T30	CHEM 1014 1020	Hierro
#29	AnnotatorNotes T30	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T31	PROC 1022 1061	Índice de Saturación de la Transferrina
#30	AnnotatorNotes T31	C1277709; Transferrin saturation measurement; Laboratory Procedure
T32	DISO 1101 1113	alteraciones
#31	AnnotatorNotes T32	C0221423; Illness (finding); Sign or Symptom
T33	PROC 1270 1282	intervención
#32	AnnotatorNotes T33	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T34	CHEM 1305 1308	ALA
#33	AnnotatorNotes T34	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T35	Observation 1382 1409	reducción de los leucocitos
#34	AnnotatorNotes T35	C0750394; White blood cell count decreased; Finding
T36	ANAT 1441 1452	neutrófilos
#35	AnnotatorNotes T36	C0027950; neutrophil; Cell
T37	CHEM 1485 1491	Hierro
#36	AnnotatorNotes T37	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T38	ANAT 1492 1498	Sérico
#37	AnnotatorNotes T38	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T39	CHEM 1546 1549	ALA
#38	AnnotatorNotes T39	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T40	CHEM 1558 1567	adyuvante
#39	AnnotatorNotes T40	C0001551; Immunologic Adjuvants; Immunologic Factor · Pharmacologic Substance
T41	CHEM 1655 1661	hierro
#40	AnnotatorNotes T41	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T42	CHEM 1709 1716	metales
#41	AnnotatorNotes T42	C0025552; Metals; Inorganic Chemical
T43	CHEM 1724 1737	ácido lipoico
#42	AnnotatorNotes T43	C0023791; thioctic acid; Organic Chemical · Pharmacologic Substance · Vitamin
T44	DISO 1834 1852	anemia ferropénica
#43	AnnotatorNotes T44	C0162316; Iron deficiency anemia; Disease or Syndrome
T45	DISO 1867 1878	hipertensos
#44	AnnotatorNotes T45	C0020538; Hypertensive disease; Disease or Syndrome
T46	PROC 32 50	recuento de sangre
#45	AnnotatorNotes T46	C0005771; Blood Cell Count; Laboratory Procedure
T47	ANAT 233 241	Arterial
#46	AnnotatorNotes T47	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T48	PROC 918 931	Hierro Sérico
#47	AnnotatorNotes T48	C1318312; Serum iron measurement; Laboratory Procedure
T49	PROC 933 942	Ferritina
#48	AnnotatorNotes T49	C0373607; Ferritin measurement; Laboratory Procedure
T50	PROC 944 982	Capacidad Latente de Enlace del hierro
T51	PROC 984 1020	Capacidad Total de Enlace del Hierro
#49	AnnotatorNotes T51	C1283048; Iron binding capacity total measurement; Laboratory Procedure
T52	CHEM 1049 1061	Transferrina
#50	AnnotatorNotes T52	C0040679; Transferrin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T53	PROC 1070 1082	Transferrina
#51	AnnotatorNotes T53	C0202105; Transferrin measurement; Laboratory Procedure
T54	ANAT 1399 1409	leucocitos
#52	AnnotatorNotes T54	C0023516; Leukocytes; Cell
T55	PROC 1474 1498	niveles de Hierro Sérico
#53	AnnotatorNotes T55	C1318312; Serum iron measurement; Laboratory Procedure
T56	PROC 1522 1541	administración oral
#54	AnnotatorNotes T56	C0001563; Administration, Oral; Therapeutic or Preventive Procedure | C1273553; Oral administration of treatment; Therapeutic or Preventive Procedure
T57	PROC 1618 1628	leucograma
#55	AnnotatorNotes T57	C1954459; Leukogram panel; Laboratory Procedure
T58	PHYS 56 77	metabolismo de hierro
#56	AnnotatorNotes T58	C0596803; iron metabolism; Molecular Function
T59	LIVB 81 90	pacientes
#57	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Neg_cue 268 270	no
T61	PHYS 344 366	metabolismo del hierro
#58	AnnotatorNotes T61	C0596803; iron metabolism; Molecular Function
T62	PHYS 454 476	metabolismo del hierro
#59	AnnotatorNotes T62	C0596803; iron metabolism; Molecular Function
T63	LIVB 480 490	individuos
#60	AnnotatorNotes T63	C0027361; Persons; Population Group
T64	Neg_cue 509 512	sin
T65	LIVB 632 642	individuos
#61	AnnotatorNotes T65	C0027361; Persons; Population Group
T66	Dose 727 733	600 mg
T67	Frequency 733 737	/día
T68	Duration 750 762	doce semanas
T69	LIVB 765 778	grupo control
#62	AnnotatorNotes T69	C0009932; Control Groups; Group
T70	Route 1537 1541	oral
#63	AnnotatorNotes T70	C1527415; Oral Route of Drug administration; Functional Concept
T71	PHYS 1696 1716	quelación de metales
#64	AnnotatorNotes T71	C1154714; Metal chelating activity; Molecular Function
T73	LIVB 1856 1866	individuos
#65	AnnotatorNotes T73	C0027361; Persons; Population Group
T72	PHYS 390 409	efecto antioxidante
#66	AnnotatorNotes T72	C3179302; Antioxidant Effect; Physiologic Function
T74	LIVB 687 704	grupo tratamiento
#67	AnnotatorNotes T74	C5205742; Treatment Group; Population Group
T75	PHYS 1601 1613	hematológica
#68	AnnotatorNotes T75	C0221130; Hematologic function; Organ or Tissue Function
T76	PHYS 1641 1650	absorción
#69	AnnotatorNotes T76	C2347023; Biological Absorption; Organism Function
T77	Observation 1591 1613	respuesta hematológica
#70	AnnotatorNotes T77	C4054793; Hematologic Response; Finding
A1	Assertion T12 Negated
A2	Assertion T18 Negated
R1	Negation Arg1:T64 Arg2:T18	
R2	Negation Arg1:T60 Arg2:T12	
T78	Spec_cue 1797 1803	podría
A3	Assertion T44 Speculated
T79	Observation 1 7	Efecto
#71	AnnotatorNotes T79	C1518681; Outcome of Therapy; Finding (?)
R3	Causes Arg1:T1 Arg2:T79	
R4	Experiences Arg1:T59 Arg2:T4	
R5	Experiences Arg1:T59 Arg2:T58	
R6	Experiences Arg1:T59 Arg2:T46	
R7	Experiences Arg1:T59 Arg2:T1	
R8	Experiences Arg1:T59 Arg2:T79	
R9	Used_for Arg1:T7 Arg2:T8	
R10	Used_for Arg1:T6 Arg2:T8	
#72	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
R11	Location_of Arg1:T47 Arg2:T11	
R12	Location_of Arg1:T47 Arg2:T9	
R13	Used_for Arg1:T13 Arg2:T61	
R14	Used_for Arg1:T16 Arg2:T62	
T80	Observation 191 213	reducir daño oxidativo
R15	Causes Arg1:T8 Arg2:T80	
R16	Before Arg1:T10 Arg2:T80	
R17	Overlap Arg1:T10 Arg2:T11	
R18	Overlap Arg1:T10 Arg2:T9	
R19	Causes Arg1:T14 Arg2:T72	
R23	Experiences Arg1:T63 Arg2:T17	
R24	Experiences Arg1:T63 Arg2:T18	
R25	Overlap Arg1:T17 Arg2:T18	
R26	Experiences Arg1:T63 Arg2:T62	
R27	Experiences Arg1:T63 Arg2:T15	
R28	Experiences Arg1:T63 Arg2:T14	
R29	Experiences Arg1:T63 Arg2:T72	
R31	Experiences Arg1:T65 Arg2:T21	
R32	Before Arg1:T20 Arg2:T22	
R33	Before Arg1:T20 Arg2:T24	
R34	Experiences Arg1:T69 Arg2:T24	
R35	Used_for Arg1:T23 Arg2:T22	
R36	Experiences Arg1:T74 Arg2:T22	
R37	Has_Frequency Arg1:T23 Arg2:T67	
R38	Has_Dose_or_Strength Arg1:T23 Arg2:T66	
R39	Has_Duration_or_Interval Arg1:T23 Arg2:T68	
R40	Has_Duration_or_Interval Arg1:T24 Arg2:T68	
R41	Experiences Arg1:T65 Arg2:T22	
R42	Experiences Arg1:T74 Arg2:T21	
R43	Experiences Arg1:T69 Arg2:T21	
R44	Location_of Arg1:T28 Arg2:T48	
R45	After Arg1:T26 Arg2:T25	
R46	Before Arg1:T26 Arg2:T25	
R47	After Arg1:T48 Arg2:T25	
R48	Before Arg1:T48 Arg2:T25	
R49	After Arg1:T49 Arg2:T25	
R50	Before Arg1:T49 Arg2:T25	
R51	After Arg1:T50 Arg2:T25	
R52	Before Arg1:T50 Arg2:T25	
R53	After Arg1:T51 Arg2:T25	
R54	Before Arg1:T51 Arg2:T25	
R55	After Arg1:T31 Arg2:T25	
R56	Before Arg1:T31 Arg2:T25	
R57	After Arg1:T53 Arg2:T25	
R58	Before Arg1:T53 Arg2:T25	
T81	CONC 1152 1164	t de Student
#73	AnnotatorNotes T81	C0871453; Students T Test; Intellectual Product
T82	CONC 1170 1196	análisis de varianza ANOVA
#74	AnnotatorNotes T82	C0002780; Analysis of Variance; Quantitative Concept
T83	Food 1287 1297	suplemento
#75	AnnotatorNotes T83	C0242295; Dietary Supplements; Food
R59	Combined_with Arg1:T34 Arg2:T83	
R60	Before Arg1:T83 Arg2:T35	
R61	Used_for Arg1:T83 Arg2:T33	
R62	Before Arg1:T83 Arg2:T5	
T84	Quantifier_or_Qualifier 1410 1417	totales
#76	AnnotatorNotes T84	C0439810; Total; Qualitative Concept
R63	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T84	
T85	Observation 1455 1498	reducciones en los niveles de Hierro Sérico
#77	AnnotatorNotes T85	C0235988; Serum iron low (finding); Finding 
R64	Before Arg1:T83 Arg2:T85	
R66	Location_of Arg1:T38 Arg2:T55	
R67	Location_of Arg1:T38 Arg2:T85	
T86	Observation 1455 1484;1501 1504	reducciones en los niveles de ISI
R68	Before Arg1:T83 Arg2:T86	
R69	Location_of Arg1:T38 Arg2:T86	
R70	Used_for Arg1:T39 Arg2:T56	
R71	Has_Route_or_Mode Arg1:T39 Arg2:T70	
T87	Quantifier_or_Qualifier 1568 1579	terapéutico
#78	AnnotatorNotes T87	C0302350; Therapeutic; Functional Concept
R72	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T87	
R73	Used_for Arg1:T41 Arg2:T76	
R80	Causes Arg1:T43 Arg2:T71	
R81	Used_for Arg1:T42 Arg2:T71	
R82	Speculation Arg1:T78 Arg2:T44	
R83	Before Arg1:T43 Arg2:T44	
R84	Overlap Arg1:T44 Arg2:T45	
R85	Experiences Arg1:T73 Arg2:T44	
R86	Experiences Arg1:T73 Arg2:T45	
R87	Experiences Arg1:T73 Arg2:T71	
R88	Experiences Arg1:T73 Arg2:T43	
R20	Has_Frequency Arg1:T24 Arg2:T67	
R21	Has_Dose_or_Strength Arg1:T24 Arg2:T66	
#79	AnnotatorNotes T86	C0919785; Decreased transferrin saturation; Finding
A4	Experiencer T59 Patient
A5	Experiencer T63 Patient
A6	Experiencer T65 Patient
A7	Experiencer T74 Patient
A8	Experiencer T69 Patient
A9	Experiencer T73 Patient
R22	Has_Result_or_Value Arg1:T55 Arg2:T85	
